Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study
H. A. P. Pols, Dieter Felsenberg, David A. Hanley, J Štěpán, Manuel Muñoz‐Torres, Terence J. Wilkin, Qin-sheng Ge, A.M. Galich, K. Vandormael, A.J.P. Yates, B Stych, for the Fosamax® International Trial Study Group
Osteoporosis International, 1999
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.
- Exercise and bone mineral density at the femoral neck in postmenopausal women: A meta-analysis of controlled clinical trials with individual patient data 2006
- Current Physical Activity is Related to Bone Mineral Density in Males but not in Females 2007
- Demonstration that bone mineral density of the lumbar spine, trochanter, and femoral neck is higher in black than in white young men 1995
- Can the Weight-Bearing Capacity of the Femoral Neck be Estimated by Physical Measurements on the Greater Trochanter? 1988
- Relationship of bone mineral density and axis length of femoral neck with hip fracture in the aged 2000
- Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women 1991
- Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling 1995
- Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. 1993
- Risk of hip fracture among women with vertebral fractures 1990
- Hospital del Mar, Barcelona 1994